Chief Executive Officer Seth Maheu was the 15th employee of Millennium Health, one of the largest urine drug testing laboratories in the country. That tenure enabled him to observe the development of a startup into a $2B business, which has provided him with critical operational insight.
Subsequently, Mr. Maheu was able to apply this unique exposure — along with his 10+ years of clinical sales experience — into the acquisition of San Diego-based Birdrock Laboratories in 2017.
As CEO of Birdrock, Mr. Maheu oversaw substantial growth, growing the laboratory from a situation of negative revenue into a thriving, $12M annual operation.
It is exciting to see Saba in action. You can quickly sense his understanding and passion while he works the team towards a goal.
Extensive experience and expertise in a fast-moving, customer-service-oriented production environment makes Mr. Maheu an apt choice to lead Sequence Sciences as its Chief Executive Officer.
Get a Quote
Need a high-quality biostorage facility for your critical specimens? We got that.